Parsing the neuroanatomy of schizophrenia to enhance the translational validity of preclinical models - a multidisciplinary perspective

People with schizophrenia can experience a range of symptoms, typically classified as positive (such as hallucinations, delusions), negative (such as avolition, anhedonia) or cognitive (such as attentional or working memory impairments). The accumulation of evidence from EEG, and structural and functional imaging, combined with post-mortem neurochemistry and pathology, has gradually focussed attention on altered function in a core neural circuitry as underlying the aetiology of schizophrenia. The principal circuits apparently fundamental to positive symptoms (e.g. auditory pathway, including auditory cortex) overlap with those apparently fundamental to negative/cognitive symptoms (e.g. ventral striatum, ventral tegmental area) at prefrontal cortex and reticular thalamus. This review summarises the various strands of evidence that lead to these conclusions, considers how this circuitry might be selectively affected according to our understanding of the causes of the disease, and then highlights how the knowledge of regionally-specific electrophysiological, imaging and neurochemical endophenotypes could be better exploited for translational purposes.

Authors

Institutions

Publication Details

Journal
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Published
2026-01-27
DOI
https://doi.org/10.1016/j.pnpbp.2026.111628
Primary Topic
Neural dynamics and brain function
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Parsing the neuroanatomy of schizophrenia to enhance the translational validity of preclinical models - a multidisciplinary perspective

Brian J. Morris
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Neural dynamics and brain function
article

Parsing the neuroanatomy of schizophrenia to enhance the translational validity of preclinical models - a multidisciplinary perspective

Brian J. Morris
article en

Abstract

People with schizophrenia can experience a range of symptoms, typically classified as positive (such as hallucinations, delusions), negative (such as avolition, anhedonia) or cognitive (such as attentional or working memory impairments). The accumulation of evidence from EEG, and structural and functional imaging, combined with post-mortem neurochemistry and pathology, has gradually focussed attention on altered function in a core neural circuitry as underlying the aetiology of schizophrenia. The principal circuits apparently fundamental to positive symptoms (e.g. auditory pathway, including auditory cortex) overlap with those apparently fundamental to negative/cognitive symptoms (e.g. ventral striatum, ventral tegmental area) at prefrontal cortex and reticular thalamus. This review summarises the various strands of evidence that lead to these conclusions, considers how this circuitry might be selectively affected according to our understanding of the causes of the disease, and then highlights how the knowledge of regionally-specific electrophysiological, imaging and neurochemical endophenotypes could be better exploited for translational purposes.

Progress in Neuro-Psychopharmacology and Biological PsychiatryVol. 145
University of Glasgow (GB)
Openalex Percentile: Top 78%
Neural dynamics and brain function
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Parsing the neuroanatomy of schizophrenia to enhance the translational validity of preclinical models - a multidisciplinary perspective — Brian J. Morris · Progress in Neuro-Psychopharmacology and Biological Psychiatry (2026) | TGRS Research Map | TGRS